MFDS — authorised 12 December 1995
- Marketing authorisation holder: COVIS PHARMA SARL
- Status: likely_approved
🇰🇷 Rilutek in South Korea
MFDS authorised Rilutek on 12 December 1995
Marketing authorisation
Rilutek in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in South Korea
Frequently asked questions
Is Rilutek approved in South Korea?
Yes. MFDS authorised it on 12 December 1995.
Who is the marketing authorisation holder for Rilutek in South Korea?
COVIS PHARMA SARL holds the South Korean marketing authorisation.